Abstract
Selective inactivation of a target gene by antisense mechanisms is an important biological tool to delineate specific functions of the gene product. Approaches mediated by ribozymes and RNA-cleaving DNA enzymes (DNA enzymes) are more attractive because of their ability to catalytically cleave the target RNA. DNA enzymes have recently gained a lot of importance because they are short DNA molecules with simple structures that are expected to be stable to the nucleases present inside a mammalian cell. We have designed a strategy to identify accessible cleavage sites in HIV-1 gag RNA from a pool of random DNA enzymes, and for isolation of DNA enzymes. A pool of random sequences (all 29 nucleotides long) that contained the earlier-identified 10-23 catalytic motif were tested for their ability to cleave the target RNA. When the pool of random DNA enzymes was targeted to cleave between any A and U nucleotides, DNA enzyme 1836 was identified. Although several DNA enzymes were identified using a pool of DNA enzymes that was completely randomized with respect to its substrate-binding properties, DNA enzyme-1810 was selected for further characterization. Both DNA enzymes showed target-specific cleavage activities in the presence of Mg(2+) only. When introduced into a mammalian cell, they showed interference with HIV-1-specific gene expression. This strategy could be applied for the selection of desired target sites in any target RNA.
Full Text
The Full Text of this article is available as a PDF (213.0 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Adachi A., Gendelman H. E., Koenig S., Folks T., Willey R., Rabson A., Martin M. A. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol. 1986 Aug;59(2):284–291. doi: 10.1128/jvi.59.2.284-291.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Banerjea A. C., Joklik W. K. Reovirus protein sigma 1 translated in vitro, as well as truncated derivatives of it that lack up to two-thirds of its C-terminal portion, exists as two major tetrameric molecular species that differ in electrophoretic mobility. Virology. 1990 Nov;179(1):460–462. doi: 10.1016/0042-6822(90)90315-i. [DOI] [PubMed] [Google Scholar]
- Basu S., Sriram B., Goila R., Banerjea A. C. Targeted cleavage of HIV-1 coreceptor-CXCR-4 by RNA-cleaving DNA-enzyme: inhibition of coreceptor function. Antiviral Res. 2000 May;46(2):125–134. doi: 10.1016/s0166-3542(00)00075-9. [DOI] [PubMed] [Google Scholar]
- Dash B. C., Harikrishnan T. A., Goila R., Shahi S., Unwalla H., Husain S., Banerjea A. C. Targeted cleavage of HIV-1 envelope gene by a DNA enzyme and inhibition of HIV-1 envelope-CD4 mediated cell fusion. FEBS Lett. 1998 Jul 24;431(3):395–399. doi: 10.1016/s0014-5793(98)00799-6. [DOI] [PubMed] [Google Scholar]
- Goila R., Banerjea A. C. Sequence specific cleavage of the HIV-1 coreceptor CCR5 gene by a hammer-head ribozyme and a DNA-enzyme: inhibition of the coreceptor function by DNA-enzyme. FEBS Lett. 1998 Oct 2;436(2):233–238. doi: 10.1016/s0014-5793(98)01137-5. [DOI] [PubMed] [Google Scholar]
- Husain S., Goila R., Shahi S., Banerjea A. First report of a healthy Indian heterozygous for delta 32 mutant of HIV-1 co-receptor-CCR5 gene. Gene. 1998 Jan 30;207(2):141–147. doi: 10.1016/s0378-1119(97)00617-3. [DOI] [PubMed] [Google Scholar]
- Kwon H. Y., Bultman S. J., Löffler C., Chen W. J., Furdon P. J., Powell J. G., Usala A. L., Wilkison W., Hansmann I., Woychik R. P. Molecular structure and chromosomal mapping of the human homolog of the agouti gene. Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9760–9764. doi: 10.1073/pnas.91.21.9760. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Paik S. Y., Banerjea A., Chen C. J., Ye Z., Harmison G. G., Schubert M. Defective HIV-1 provirus encoding a multitarget-ribozyme inhibits accumulation of spliced and unspliced HIV-1 mRNAs, reduces infectivity of viral progeny, and protects the cells from pathogenesis. Hum Gene Ther. 1997 Jun 10;8(9):1115–1124. doi: 10.1089/hum.1997.8.9-1115. [DOI] [PubMed] [Google Scholar]
- Santiago F. S., Lowe H. C., Kavurma M. M., Chesterman C. N., Baker A., Atkins D. G., Khachigian L. M. New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth after injury. Nat Med. 1999 Nov;5(11):1264–1269. doi: 10.1038/15215. [DOI] [PubMed] [Google Scholar]
- Santoro S. W., Joyce G. F. A general purpose RNA-cleaving DNA enzyme. Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4262–4266. doi: 10.1073/pnas.94.9.4262. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wu Y., Yu L., McMahon R., Rossi J. J., Forman S. J., Snyder D. S. Inhibition of bcr-abl oncogene expression by novel deoxyribozymes (DNAzymes). Hum Gene Ther. 1999 Nov 20;10(17):2847–2857. doi: 10.1089/10430349950016573. [DOI] [PubMed] [Google Scholar]
- Zhang X., Xu Y., Ling H., Hattori T. Inhibition of infection of incoming HIV-1 virus by RNA-cleaving DNA enzyme. FEBS Lett. 1999 Sep 17;458(2):151–156. doi: 10.1016/s0014-5793(99)01149-7. [DOI] [PubMed] [Google Scholar]